Nuvalent, INC. (NUVL) SEC Filings — 2025
16 SEC filings for Nuvalent, INC. (NUVL) in 2025.
Filings
- Nuvalent, INC. 8-K Filing — 8-K · Dec 16, 2025
- Nuvalent, Inc. Reports Director and Officer Changes — 8-K · Dec 10, 2025
- Nuvalent Enters Material Definitive Agreement — 8-K · Nov 20, 2025
- Nuvalent, INC. 8-K Filing — 8-K · Nov 17, 2025
- Nuvalent's Q3 Net Loss Widens 45% Amid Soaring R&D Costs — 10-Q · Oct 30, 2025
- Nuvalent Files 8-K for Other Events — 8-K · Sep 22, 2025
- Nuvalent's Q2 Loss Widens to $75.2M Amid R&D Surge — 10-Q · Aug 7, 2025
- Nuvalent, Inc. Files 8-K — 8-K · Jul 21, 2025
- BioNTech to Acquire Nuvalent for $1.1 Billion — 8-K · Jun 24, 2025
- Nuvalent Appoints New Director to Board — 8-K · Jun 20, 2025
- Nuvalent Reports Director Departure, New CMO Appointment — 8-K · Jun 10, 2025
- Nuvalent Files Q1 2025 10-Q, Details Drug Pipeline — 10-Q · May 8, 2025
- Nuvalent DEF 14A: Executive Compensation Details — DEF 14A · Apr 28, 2025
- Nuvalent Appoints New Director to Board — 8-K · Apr 17, 2025
- Nuvalent, Inc. Files 2024 10-K Annual Report — 10-K · Feb 27, 2025
- Nuvalent Files 8-K: Other Events & Exhibits — 8-K · Jan 14, 2025